Sign up now

Sally Adams to Join Scancell as Development Director

Dr Sally Adams

News

Sally Adams to Join Scancell as Development Director

09 May, 2014

Published over 12 years ago. See the latest and most current information on News.

Scancell Holdings Plc

1 min read

Request information

Richard Goodfellow, Joint CEO of Scancell, said: “Sally has already worked closely with the Scancell team for several years. She has played a key role in the planning and execution of our successful clinical trial of SCIB1 in patients with metastatic melanoma and we are delighted that Sally will be joining our Board at such a pivotal juncture in the Company’s history. With her industry, scientific and drug development knowledge, Sally will continue to play an important role in the development of our ImmunoBody® and Moditope® platforms.”

Latest News

ProteinTalks uses experimental proteomics to predict drug responses

News

ProteinTalks uses experimental proteomics to pr...

A computational cell model developed by a research team in Hangzhou has used time-resolved protei...

High-dose flu vaccine cuts hospital admissions in elderly with lung disease

Laboratory events news

High-dose flu vaccine cuts hospital admissions...

Combined results from two large clinical trials suggest that high-dose influenza vaccination offe...

Gut bacterial molecule may be biomarker of rare disease of liver and bile duct

Research news

Gut bacterial molecule may be biomarker of rare...

Researchers have identified imidazole propionate, a metabolite produced by gut bacteria, as a pos...

Helicobacter pylori may be linked to more than 20 per cent of bowel cancer cases

Research news

Helicobacter pylori may be linked to more than...

Exploratory analysis finds link between H. pylori exposure and bowel cancer risk, with those born...

Dormant chickenpox virus is an under-recognised cause of serious disease

Research news

Dormant chickenpox virus is an under-recognised...

Varicella zoster virus, the cause of chickenpox and shingles, can trigger stroke, vision loss and...

Severe type 2 asthma linked to subtle changes of structures within the brain

Research news

Severe type 2 asthma linked to subtle changes o...

Research presented at the recent European Respiratory Society Congress in Barcelona, Spain, sugge...

Test of AlphaFold 3 exposes limitations in amyloid structure prediction models

Research news

Test of AlphaFold 3 exposes limitations in amyl...

AI model generates amyloid-like structures for many non-amyloid controls underlining the need for...

ERC grant set to support neuroscience research into first-person perception

News

ERC grant set to support neuroscience research...

University of Bonn professor will receive approximately €1.5 million over five years to examine...

Bacteria produces testosterone from steroid precursor DHEA in the laboratory

Research news

Bacteria produces testosterone from steroid pre...

Scientists have identified a bacterium from the human urinary tract that can convert the steroid...

Related Stories

News

Scancell awarded Technology Grant

Scancell awarded Technology Grant

Laboratory products

DNA ImmunoBody® Patent Granted in first market

DNA ImmunoBody® Patent Granted in fir...

News

ProteinTalks uses experimental proteomics to predict drug responses

ProteinTalks uses experimental proteo...

News

ERC grant set to support neuroscience research into first-person perception

ERC grant set to support neuroscience...

ILM 51.6 Sept 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

View all digital editions

Explore Our Other Sites

Envirotech Online

Independent studies strengthen the evidence for quantitative optical gas imaging

Pollution Solutions Online

Safe drinking water worldwide

Petro Online

Independent studies strengthen the evidence for quantitative optical gas imaging

Chromatography Today

Inline degasser range upgraded with new vacuum control and pump technology